NCT06348992

ACT Combined Yoga for Parental Burnout in Parents With Autistic Children

Name: Clinical Trial NCT06348992
Creator: Harbin Medical University
Keywords: Autism Spectrum Disorder, Acceptance commitment therapy and yoga, behavioral, clinical trial, China

ACT (Acceptance Commitment Therapy) Combined With Yoga for Parental Burnout in Parents With Autistic Children: A Randomized Controlled Trial.

Harbin Medical University·ClinicalTrials.gov·behavioralRecruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Autism Spectrum Disorder
Drug/Device/Intervention: Acceptance commitment therapy and yoga
Study type: Interventional
Intervention type: behavioral

Sponsor & location

Primary sponsor: Harbin Medical University
Location: Daqing, China

Timeline & enrollment

Phase: N/A
Start date: Sep 01, 2023
End date: Dec 31, 2024
Enrollment: 60 participants

Primary outcome

Measuring parental Burnout Levels,Measuring parenting stress Levels

Summary

OBJECTIVE: To explore the intervention effect of ACT combined with a yoga intervention program on parenting burnout in parents with ASD.  METHODS: This study used a combination of qualitative research and quantitative analysis to examine the intervention effects of an ACT-centered intervention program on parenting burnout in parents of children with ASD, and to clarify the evaluations and perceptions of parents with ASD about the research program through qualitative research.  RESULTS AND CONCLUSION: To clarify the intervention effect of ACT combined with yoga intervention program on parenting burnout of ASD parents.

ICD-10 classifications

Childhood autismAtypical autismAsperger syndromeNeurotic disorder, unspecifiedMental and behavioural disorders

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06348992
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT06348992 through Pure Global AI's free database. This phase not specified trial is sponsored by Harbin Medical University and is currently Recruiting. The study focuses on Autism Spectrum Disorder. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.